Skip to main content
. 2014 Jul 31;8:1419–1433. doi: 10.2147/OPTH.S65263

Table S3.

Liquid polyol-based artificial tears available on the market

Name Active ingredients Preservatives
Oasis® Tears 0.2% glycerin (15%) No
Oasis® Tears Plus 0.2% glycerin (30%) No
Advanced Eye Relief™ “Environmental” 1.0% glycerin BAK
Advanced Eye Relief™ “Rejuvenation” 0.3% glycerin
1.0% propylene glycol
BAK
Blink® Tears 0.25% polyethylene glycol 400 Preserved-forma
Hyaluronic acid OcuPure® (stabilized oxychloro complex)
Blink® Gel Tears 0.25% polyethylene glycol 400
Hyaluronic acid
OcuPure® (stabilized oxychloro complex)
Systane® Balance 0.6% propylene glycol Polyquad® (polyquaternium-1)
Systane® Gel Drops 0.4% polyethylene glycol 400
0.3% propylene glycol
Polyquad® (polyquaternium-1)
Systane® 0.4% polyethylene glycol 400 Preserved-forma
0.3% propylene glycol Polyquad® (polyquaternium-1)
Systane® Ultra 0.4% polyethylene glycol 400 Preserved-forma
0.3% propylene glycol Polyquad® (polyquaternium-1)
Soothe® 0.6% glycerin
0.6% propylene glycol
No
Viva Drops® 1.0% polysorbate 80 No

Notes:

a

Both preserved and preservative-free formulations commercially available. Manufacturers are as follows: Oasis®, Oasis Medical, Inc., Glendora, CA, USA; Advanced Eye Relief™, Bausch & Lomb Incorporated, Bridgewater, NJ, USA; Blink®, Abbott Laboratories Inc., Abbott Park, Illinois, USA; Systane®, Alcon Laboratories, Inc., Fort Worth, TX, USA; Soothe®, Bausch & Lomb Incorporated; Viva Drops®, Dakota Laboratories, LLC, Mitchell, SD, USA; Polyquad®, Alcon Laboratories, Inc.; OcuPure®, Abbott Laboratories Inc.

Abbreviation: BAK, benzalkonium chloride.